- Home
- WISA vs BRTX Comparison
WISA vs BRTX Comparison
Compare WISA & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WISA
- BRTX
- Stock Information
- Founded
- WISA 2010
- BRTX 1997
- Country
- WISA United States
- BRTX United States
- Employees
- WISA N/A
- BRTX N/A
- Industry
- WISA Semiconductors
- BRTX Managed Health Care
- Sector
- WISA Technology
- BRTX Health Care
- Exchange
- WISA Nasdaq
- BRTX Nasdaq
- Market Cap
- WISA 12.4M
- BRTX 11.3M
- IPO Year
- WISA 2018
- BRTX N/A
- Fundamental
- Price
- WISA $1.49
- BRTX $1.97
- Analyst Decision
- WISA Strong Buy
- BRTX Strong Buy
- Analyst Count
- WISA 1
- BRTX 1
- Target Price
- WISA $11.00
- BRTX $18.00
- AVG Volume (30 Days)
- WISA 2.1M
- BRTX 50.3K
- Earning Date
- WISA 11-15-2024
- BRTX 11-12-2024
- Dividend Yield
- WISA N/A
- BRTX N/A
- EPS Growth
- WISA N/A
- BRTX N/A
- EPS
- WISA N/A
- BRTX N/A
- Revenue
- WISA $2,192,000.00
- BRTX $377,000.00
- Revenue This Year
- WISA $19.97
- BRTX $482.76
- Revenue Next Year
- WISA $155.10
- BRTX $212.24
- P/E Ratio
- WISA N/A
- BRTX N/A
- Revenue Growth
- WISA N/A
- BRTX 189.55
- 52 Week Low
- WISA $1.15
- BRTX $1.03
- 52 Week High
- WISA $16.50
- BRTX $3.67
- Technical
- Relative Strength Index (RSI)
- WISA 37.06
- BRTX 66.37
- Support Level
- WISA $1.82
- BRTX $1.75
- Resistance Level
- WISA $2.29
- BRTX $2.12
- Average True Range (ATR)
- WISA 0.23
- BRTX 0.16
- MACD
- WISA -0.07
- BRTX 0.05
- Stochastic Oscillator
- WISA 2.46
- BRTX 79.47
About WISA WiSA Technologies Inc.
WiSA Technologies Inc is a provider of immersive, wireless sound technology for intelligent devices and next-generation home entertainment systems through the sale of module components to audio companies as well as audio products to resellers and consumers.. The company works with consumer electronics companies, technology providers, retailers, and ecosystem partners to make immersive audio an enjoyable experience. The company has a geographic presence in Asia Pacific, North America, Europe and, other.
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.